ARS Pharma
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11682 El Camino Real Ste 300, San Diego,...Phone Number
(858) 771-9307Website
www.ars-pharma.comRevenue
$99 MillionStock Symbol
SPRYIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
1
1
1
About ARS Pharma
ARS Pharm operates as a pharmaceutical company. The Company develops an intranasal epinephrine spray with a unique absorption technology to save patients from allergic reactions of food, medications, and insect bites. Established in 2015, ARS Pharm is headquartered in San Diego, California, United States.Explore more
ARS Pharma Org Chart
Get the full picture
Sign in to uncover key details.
KY
Director, Associate General Counsel - Corpora...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ARS Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
ARS Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at ARS Pharma
Product Launch: Get notified when ARS Pharma launches new products
Click to see if ARS Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on ARS Pharma recently announced quarterly report
Check if ARS Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ARS Pharma has new funding data
Check out if ARS Pharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to ARS Pharma
Compare insights from companies similar to ARS Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ARS Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ARS Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ARS Pharma.
ARS Pharma financials insights
Gather financial insights about ARS Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series C
$20M
2021
Series D
$55M
ARS Pharma Tech Stack
A closer look at the technologies used by ARS Pharma
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Person-Based
Financial Planning, Forecasting
Person-Based
Product Launch, Business Finance, Finance
ARS Pharma News & Media
Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies
Former NFL quarterback and 2026 Hall of Fame inductee highlights daily life for people living with severe food allergies and role preparedness plays in living fullyARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update
Q1 2026 total revenue of $22.7 million including neffy® (epinephrine nasal spray) U.S. net product revenue of $17.5 millionARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering patients and their caregivers to better protect against severe allergic reactions that can lead to anaphylaxis, today announced the appointment of Donn Casale as President, effective June 1, 2026. Richard Lowenthal will continue to lead ARS Pharma as Chief Executive Officer.ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results
SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Friday, May 15, 2026, at 5:30 a.m. PT / 8:30 a.m. ET to discuss its first quarter 2026 financial results and business highlights.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ARS Pharma
Sign Up For FreeTo access detailed company insights
ARS Pharm operates as a pharmaceutical company. The Company develops an intranasal epinephrine spray with a unique absorption technology to save patients from allergic reactions of food, medications, and insect bites. Established in 2015, ARS Pharm is headquartered in San Diego, California, United States.... Read More
